Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6650689 | 0.85 | L3MBTL1 (0.40) | L3MBTL1MEN1KMT2AKDM4EMAPT | |
| SCHEMBL21721828 | 0.83 | HTR1D (0.43) | L3MBTL1MEN1KMT2AOPRK1FDPS | |
| SCHEMBL6651872 | 0.75 | LMNA (0.36) | L3MBTL1MEN1KMT2AKDM4EOPRK1 | |
| SCHEMBL1044189 | 0.75 | KMT2A (0.54) | MEN1KMT2AKDM4EMAPTFDPS | |
| SCHEMBL27475942 | 0.74 | MEN1 (0.41) | MEN1KMT2AOPRK1FDPSSMN1; SMN2 | |
| SCHEMBL1044399 | 0.74 | NR4A1 (0.46) | L3MBTL1MEN1KMT2AKDM4EMAPT | |
| Hydrochloric Acid SCHEMBL1875423 | 0.74 | KMT2A (0.53) | MEN1KMT2AKDM4EMAPTFDPS | |
| SCHEMBL6650490 | 0.72 | MEN1 (0.37) | L3MBTL1MEN1KMT2AKDM4EMAPT | |
| Ethylene SCHEMBL28111857 | 0.72 | KMT2A (0.51) | L3MBTL1MEN1KMT2AKDM4EMAPT | |
| SCHEMBL4063363 | 0.72 | FDPS (0.48) | MEN1KMT2AKDM4EOPRK1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1103243-B1 | UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P | ESTEVE LABOR DR (ES) | 2004-01-07 | — | — | EP | claimed |